Alex Waldron

[Alex Waldron @alexcwaldron]

Pear’s shadow effect: Data from a Medicaid digital health experiment does the policy rounds https://t.co/bbNYJzBuE1 via @statnews
Nice article by Mario Aguilar showing the benefit of reSET and reSET-O to patients in need at MassHealth. Hopefully this will move legislators

[Alex Waldron @alexcwaldron]

Pharma can’t let Big Tech win the race for medical AI https://t.co/BtW4Ye3zqk via @statnews

[Alex Waldron @alexcwaldron]

Highmark Blue Cross Blue Shield Delaware Taps Wellinks for Virtual COPD Care https://t.co/vDwCGGJezj

[Alex Waldron @alexcwaldron]

Sorry, the government’s not paying for your therapy app https://t.co/zcLOSwOWfN via @politico

Action is needed for these critical prescription digital therapeutics to become reimbursed. Good luck to everyone moving this legislation forward

[Wellinks @WellinksHealth]

We are proud Krista Gullickson is one of our clinical coaches. She recently advocated for legislation to increase access to cardiopulmonary rehab services, an essential treatment to help those with COPD recover from complications.

#COPD #virtualcare #patientaccess

[Alex Waldron @alexcwaldron]

People Living with COPD Want Innovation in Care Delivery, According to Wellinks Survey https://t.co/o0A6YcASlS

[Wellinks @WellinksHealth]

Wellinks President @GeoffMatous and Chief Medical Officer Dr. Abi Sundaramoorthy recently joined the @institutehv's @Race2Value podcast for a deep dive into value-based care and the COPD care continuum with hosts @Eric_S_Weaver and @DanielChipping.

[Wellinks @WellinksHealth]

Today is National Lung Health Day, a time to recognize all the essential bodily functions your lungs support. This organ is vital in supporting our health and wellness. Learn more about how we support our patient's lung health goals here: https://t.co/FwxpUO2gAP

[Wellinks @WellinksHealth]

Last month we announced the interim results of ASPIRE. The trial has now closed and our teams are hard at work analyzing the full results. Learn more and sign up to be the first to receive them here: https://t.co/IUmmz5k3WH

#COPD #BreatheFreely #LiveFully #Wellinks

[Wellinks @WellinksHealth]

On October 5, our Chief Medical Officer Dr. Abi Sundaramoorthy will be joining a panel at the @BeckersHR Health IT + Digital Health + RCM Annual Meeting to discuss her experience at the intersection of VC and health tech.

To register, visit: https://t.co/ZhWSIkJbVB

[Alex Waldron @alexcwaldron]

Nice to see the Commissioner calling for solutions for chronic diseases. We at @WellinksHealth have developed a virtual-first solution for the care and management of COPD that meets patients where they are and allows them to live fully and breathe freely
https://t.co/nzbjbUF4yU

[Alex Waldron @alexcwaldron]

I’m excited to announce @Wellinks’ latest clinical study in partnership with @HartfordHealthC. Together, we’re working to reduce hospital readmissions and close gaps in care for people with COPD. https://t.co/2o5Jcq0utM

[Alex Waldron @alexcwaldron]

As @WellinksHealth continues to refine our product offering, we are always striving to deliver more evidence-based programming to our members. This is why we are excited to announce @SparoHealth is now part of Wellinks. https://t.co/lKhimzm7Ps

[Alex Waldron @alexcwaldron]

Great partnering with HHC to improve care for people with COPD

https://t.co/OORAKHlSSx

[Alex Waldron @alexcwaldron]

I am thrilled to welcome Dr. Abi Sundaramoorthy to the @WellinksHealth team! Dr. Sundaramoorthy has a proven track record of leading successful clinical programs and fostering deep connections to put the patient first. https://t.co/K9UtVx2iK9

[Alex Waldron @alexcwaldron]

At @WellinksHealth, we know that the most important first step to building a successful virtual care model for COPD is developing a strong, clinical evidence base.

I wrote about our team’s commitment to clinical rigor: https://t.co/0nOTWZ8yCT

[Pear Therapeutics @Pear_Tx]

Today, we announced that CMS has granted a new HCPCS code for Prescription Digital Behavioral Therapy including prescription digital therapeutics (PDTs) such as Pear’s commercial products. Read more here: https://t.co/BNFnbzSwm9

[Institute for Advancing Health Value @institutehv]

Recently, @WellinksHealth announced a study w/ the @COPDFoundation. It aims to determine whether Wellinks can improve outcomes for patients w/ COPD by measuring the impact on health-related quality of life & health care resource utilization. Learn more ⬇️ https://t.co/QD38nFcKqu

[Alex Waldron @alexcwaldron]

@AkiliLabs Congratulations Eddie and team!

[Akili @AkiliLabs]

Excited to announce Akili plans to go public through combination with Social Capital Suvretta Holdings Corp. I. This important step advances our work to reimagine medicine and will help us to better serve patients living with cognitive impairments $DNAA
https://t.co/OZFLrFOZIP